Swedbank AB Increases Position in CVS Health Co. (NYSE:CVS)

Swedbank AB grew its holdings in CVS Health Co. (NYSE:CVS) by 0.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,388,889 shares of the pharmacy operator’s stock after purchasing an additional 7,620 shares during the quarter. Swedbank AB owned about 0.11% of CVS Health worth $87,333,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. MidAtlantic Capital Management Inc. acquired a new position in CVS Health in the 3rd quarter valued at about $25,000. Livelsberger Financial Advisory acquired a new position in CVS Health in the third quarter valued at approximately $31,000. Reston Wealth Management LLC purchased a new position in CVS Health in the third quarter worth approximately $32,000. First Community Trust NA increased its stake in CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares during the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new position in shares of CVS Health in the 3rd quarter valued at $33,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Barclays decreased their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $59.00 to $85.00 in a report on Friday, October 4th. UBS Group upped their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Finally, Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $60.00 to $66.00 in a research note on Monday, November 18th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $72.28.

CVS Health Stock Performance

Shares of CVS stock opened at $58.01 on Monday. CVS Health Co. has a 12 month low of $52.71 and a 12 month high of $83.25. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a market cap of $73.00 billion, a P/E ratio of 14.72, a PEG ratio of 0.98 and a beta of 0.55. The firm has a fifty day moving average price of $59.21 and a 200 day moving average price of $58.63.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.21 EPS. Sell-side analysts predict that CVS Health Co. will post 5.43 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.59%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.